Medical
Japanese Drugmaker Shionogi Anticipates 2025 US Launch of Xocova COVID-19 Pill Amid Japan's Funding Cuts
Shionogi preps U.S. launch of Xocova for 2025 amid Japan's funding cuts for COVID meds. Pfizer's Paxlovid shows declining real-world efficacy.
AstraZeneca’s Lawsuit Challenging Medicare Drug Price Negotiations Dismissed by Judge
A federal judge in Delaware has dismissed AstraZeneca's lawsuit challenging Medicare's new power to negotiate prices directly with drug manufacturers.
GSK Settles California Lawsuit Over Zantac Cancer Allegations, Avoids Trial
GSK resolves California lawsuit over Zantac cancer claims in a confidential settlement, avoiding trial amid ongoing legal battles.
New Drug to Prevent Severe Food Allergies Gets FDA Approval
The US Food and Drug Administration (FDA) has approved a new drug called Xolair that could be life-changing for those with severe food allergies.
Latest News
A team of researchers has developed a "breakthrough" world-first blood test for brain cancer, which British experts said could revolutionize the detection and treatment of the disease and increase survival rates.
President Joe Biden has praised the announcement that 21.3 million people have now signed up for 2024 Obamacare health insurance plans.
Isomorphic Labs, a subsidiary of Alphabet Inc., is set to accelerate AI-driven drug discovery after it entered into strategic research collaboration agreements with Novartis AG and Eli Lilly & Co.
President Joe Biden's program under the Inflation Reduction Act of 2022, allowing Medicare to negotiate drug prices directly with manufacturers, will face major tests in 2024.
Pharmaceutical giant Pfizer said it is set to finalize its $43 billion acquisition of cancer drugmaker Seagen this week.
Turkey’s medical tourism has been booming for years, as the country boasts of some of the top medical experts in numerous fields, including hair transplantation.
Medical marijuana will be legalized after Gov. Wolf signs the bill on Sunday after the 149-46 vote in favor of marijuana legalization. However, it will take about two years before sufferers of acute ailment can get advantage of the benefits because of the several processes including regulatory and growing process.
BioPen uses 3D bioprinting technology to enable surgeons draw viable human stem cells in order to reconstruct bones of damaged joints. The product is still at the R&D stage and is still being actively tested and improved.
Pfizer, a US-based drug company, is said to dismiss its merger deal with Allergan. The US drugmaker wants to quit from the $160 billion merger deal since Washington authorities set new rules, making corporate inversions harder.
GSK Got Positive Recommendation for Its Gene Therapy for Bubble Boy Disease, Expecting Approval Soon
A gene therapy for Bubble Boy Disease has received positive evaluation from European regulatory panel, paving a way for official approval. Currently, there’s no gene therapy for the disease, and the therapy would enhance patient’s success in survival and even recovery.